Therapy for Neuroendocrine Tumors May Be Improved by Patient-Specific Dosimetry (VIDEO)

Society of Nuclear Medicine and Molecular Imaging

Caption

In neuroendocrine tumor treatment, different methods of predicting patient response may be required for different patients. Dr. Linn Hagmarker, from Sahlgrenska Academy, University of Gothenburg, Sweden, explains that by tailoring the method to the specific patient, physicians may better predict the effectiveness of treatment. The research is featured in The Journal of Nuclear Medicine (read more at http://ow.ly/DAV430pNhiL).

Credit

Linn Hagmarker, PhD, Sahlgrenska Academy, University of Gothenburg, Sweden.

Usage Restrictions

Please give appropriate credit and indicate if changes were made.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.